Documentos de Académico
Documentos de Profesional
Documentos de Cultura
ATTENTION Investors and Finance Professionals: If you are reading this you should sign up for ValuEngine's award-winning stock valuation and forecast service at the low price of $19.95/month! NO OBLIGATION, 30 Day FREE TRIAL!
Click HERE to Download a FREE Sample of the ValuEngine Small Cap Stock Newsletter
VALUATION WATCH: Our models find that overvaluation is at levels typically seen when a market pullback may occur. Overvalued stocks now make up 62% of our universe and almost 24% of the universe is calculated to be overvalued by 20% or more. Fifteen of Sixteen sectors are calculated to be overvalued.
Repro Man
--Small Cap Pick Repros Therapeutics Jumps on FDA Action Repros Therapeutics, Inc. is a United States-based company that develops products and services for the management of reproductive health. The Company's products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction. It focuses on the development of oral small molecule drugs to address major unmet medical needs in male and female health. The stock was picked for our Small Cap Stock Newsletter this month. Since inclusion in the portfolio the stock is up more than 30%.
ValuEngine Forecast
Target Price* Expected Return 3.07% 5.36% 7.18% 10.56% 12.36% 5.24%
Market Overview
Summary of VE Stock Universe
Stocks Undervalued Stocks Overvalued Stocks Undervalued by 20% Stocks Overvalued by 20% 38.02% 61.98% 15.61% 23.85%
Sector Overview
Sector
Aerospace Auto-Tires-Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Staples Finance Industrial Products Medical Multi-Sector Conglomerates Oils-Energy Retail-Wholesale Transportation Utilities
Change
0.85% 0.42% 1.40% 0.77% 0.83% 0.63% 0.62% 0.79% 0.73% 0.85% 0.37% 0.64% 0.99% 0.33% 0.79% 1.32%
MTD
1.53% 0.98% -1.91% 1.77% 2.46% 0.01% 0.91% 1.79% 1.76% 2.57% 1.07% 0.85% 0.15% 2.72% 2.17% -0.32%
YTD
6.21% 7.41% 2.01% 8.34% 9.37% 8.65% 8.57% 6.72% 8.58% 8.61% 7.27% 4.49% 8.14% 10.87% 13.20% 5.51%
Valuation
5.83% overvalued 8.03% overvalued 4.08% undervalued 11.35% overvalued 12.88% overvalued 23.36% overvalued 7.41% overvalued 23.98% overvalued 17.77% overvalued 20.23% overvalued 12.60% overvalued 10.34% overvalued 3.44% overvalued 10.65% overvalued 20.86% overvalued 7.20% overvalued
Last 12MReturn
8.15% -1.77% -29.49% 9.98% 0.26% 20.62% 6.48% 11.57% 14.12% 3.64% 5.71% 11.01% -16.36% 14.63% 0.27% 6.50%
P/E Ratio
37.01 15.47 24.41 25.35 38.33 48.47 24.75 20.4 20.94 22.86 27.23 16.42 30.41 33 24.21 18.57